[go: up one dir, main page]

HUP0004583A3 - A method for producing medicin containing liposomal encapsulated taxane - Google Patents

A method for producing medicin containing liposomal encapsulated taxane

Info

Publication number
HUP0004583A3
HUP0004583A3 HU0004583A HUP0004583A HUP0004583A3 HU P0004583 A3 HUP0004583 A3 HU P0004583A3 HU 0004583 A HU0004583 A HU 0004583A HU P0004583 A HUP0004583 A HU P0004583A HU P0004583 A3 HUP0004583 A3 HU P0004583A3
Authority
HU
Hungary
Prior art keywords
medicin
producing
liposomal encapsulated
containing liposomal
encapsulated taxane
Prior art date
Application number
HU0004583A
Other languages
English (en)
Original Assignee
Neopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharm Inc filed Critical Neopharm Inc
Publication of HUP0004583A2 publication Critical patent/HUP0004583A2/hu
Publication of HUP0004583A3 publication Critical patent/HUP0004583A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HU0004583A 1998-07-01 1999-06-29 A method for producing medicin containing liposomal encapsulated taxane HUP0004583A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/108,509 US6146659A (en) 1998-07-01 1998-07-01 Method of administering liposomal encapsulated taxane
PCT/US1999/014986 WO2000001366A1 (en) 1998-07-01 1999-06-29 A method of administering liposomal encapsulated taxane

Publications (2)

Publication Number Publication Date
HUP0004583A2 HUP0004583A2 (hu) 2001-08-28
HUP0004583A3 true HUP0004583A3 (en) 2002-04-29

Family

ID=22322617

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004583A HUP0004583A3 (en) 1998-07-01 1999-06-29 A method for producing medicin containing liposomal encapsulated taxane

Country Status (17)

Country Link
US (1) US6146659A (hu)
EP (1) EP1009384A4 (hu)
JP (2) JP2001524990A (hu)
KR (1) KR20010023522A (hu)
CN (1) CN1275076A (hu)
AU (1) AU730599B2 (hu)
BR (1) BR9906581A (hu)
CA (1) CA2301057C (hu)
EA (1) EA003678B1 (hu)
HU (1) HUP0004583A3 (hu)
IL (1) IL134747A0 (hu)
NO (1) NO20001012L (hu)
NZ (1) NZ524490A (hu)
PL (1) PL338951A1 (hu)
SK (1) SK4642000A3 (hu)
TR (1) TR200000576T1 (hu)
WO (1) WO2000001366A1 (hu)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20030087954A1 (en) * 1997-01-07 2003-05-08 Sonus Pharmaceuticals, Inc. Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
US7112338B2 (en) * 1997-03-12 2006-09-26 The Regents Of The University Of California Cationic liposome delivery of taxanes to angiogenic blood vessels
US7262173B2 (en) * 1997-03-21 2007-08-28 Georgetown University Chemosensitizing with liposomes containing oligonucleotides
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US6461637B1 (en) * 2000-09-01 2002-10-08 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US7314637B1 (en) * 1999-06-29 2008-01-01 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US7915238B2 (en) * 1999-02-01 2011-03-29 Eisai R & D Management Co., Ltd. Immunomodulatory compounds and methods of use thereof
US6835721B2 (en) * 1999-02-01 2004-12-28 Eisai Co., Ltd. Immunomodulatory compounds and methods of use thereof
US20040006242A1 (en) * 1999-02-01 2004-01-08 Hawkins Lynn D. Immunomodulatory compounds and method of use thereof
USRE43914E1 (en) * 1999-06-09 2013-01-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Method for detecting syphilis using synthetic antigens
WO2001017508A1 (en) * 1999-09-09 2001-03-15 The Regents Of The University Of California Cationic liposome delivery of taxanes to angiogenic blood vessels
AR030188A1 (es) * 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
EP1259225B1 (en) * 2000-02-04 2006-10-04 Lipoxen Technologies Limited Process of dehydration/rehydration for making liposomes
US20030129223A1 (en) * 2000-10-11 2003-07-10 Targesome, Inc. Targeted multivalent macromolecules
US20030133972A1 (en) * 2000-10-11 2003-07-17 Targesome, Inc. Targeted multivalent macromolecules
HUP0302352A3 (en) 2000-11-09 2007-03-28 Neopharm Sn-38 lipid complexes and methods of use
US20020073441A1 (en) 2000-12-13 2002-06-13 Ross Brian D. Compositions and methods for detecting proteolytic activity
WO2003030864A1 (en) * 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
CA2354486A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C7 ester substituted taxanes
WO2003018018A2 (en) * 2001-08-24 2003-03-06 Neopharm, Inc. Vinorelbine compositions and methods of use
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
CA2466443A1 (en) * 2001-11-09 2003-05-15 Neopharm, Inc. Selective treatment of il-13 expressing tumors
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
US7138512B2 (en) * 2002-04-10 2006-11-21 Georgetown University Gene SHINC-2 and diagnostic and therapeutic uses thereof
DE60328486D1 (de) 2002-05-24 2009-09-03 Angiotech Int Ag Zusammensetzungen und verfahren zur beschichtung medizinischer implantate
US20050153297A1 (en) * 2002-05-29 2005-07-14 Ateeq Ahmad Method for determining oligonucleotide concentration
WO2004006889A1 (en) * 2002-07-15 2004-01-22 Alcon, Inc. Bioerodible film for ophthalmic drug delivery
KR100533458B1 (ko) * 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
WO2004017944A1 (en) * 2002-08-23 2004-03-04 Neopharm, Inc. Liposomal gemcitabine compositions for better drug delivery
MXPA05008284A (es) * 2003-02-03 2006-03-21 Neopharm Inc Taxano y otros farmacos antineoplasicos encapsulados, liposomicos, estables, susceptibles de esterilizacion por filtracion.
JP2006517594A (ja) * 2003-02-11 2006-07-27 ネオファーム、インコーポレイティッド リポソーム製剤の製造方法
WO2004087758A2 (en) * 2003-03-26 2004-10-14 Neopharm, Inc. Il 13 receptor alpha 2 antibody and methods of use
EP1643971A2 (en) * 2003-05-22 2006-04-12 Neopharm, Inc. Liposomal formulations comprising a combination of two or more active agents
US20060078560A1 (en) * 2003-06-23 2006-04-13 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
EP1673069B1 (en) 2003-10-15 2016-10-12 SynCore Biotechnology CO., LTD Cationic liposomes comprising an active drug for use in treatment of cancer
WO2005087222A1 (en) 2004-03-05 2005-09-22 Florida State University Research Foundation, Inc. C7 lactyloxy-substituted taxanes
CA2564542C (en) * 2004-04-22 2012-11-27 Celator Pharmaceuticals, Inc. Combination formulations of anthracycline agents and cytidine analogs
JP4433918B2 (ja) * 2004-07-15 2010-03-17 コニカミノルタエムジー株式会社 画像形成方法
CA2585972A1 (en) * 2004-10-29 2006-05-11 Neopharm, Inc. Manufacturing process for liposomal preparations
CN101217946B (zh) 2004-11-02 2012-11-07 特拉维夫大学未来技术研发有限公司 水不溶性的或低水溶性药物在脂质化糖胺聚糖颗粒中的制剂和它们的制药用途
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
US20070292418A1 (en) * 2005-04-26 2007-12-20 Eisai Co., Ltd. Compositions and methods for immunotherapy
US7976852B2 (en) * 2005-04-26 2011-07-12 Eisai R&D Management Co., Ltd. Compositions and methods for cancer immunotherapy
US9233094B2 (en) 2005-05-04 2016-01-12 Medigene Ag Method of administering a cationic liposomal preparation
US8168216B2 (en) 2006-03-22 2012-05-01 Medigene Ag Treatment of triple receptor negative breast cancer
EP2010150A2 (en) 2006-04-20 2009-01-07 Amgen Inc. Stable emulsion formulations
WO2008058156A2 (en) 2006-11-06 2008-05-15 Jina Pharmaceuticals Inc. Guggulphospholipid methods and compositions
GB0905348D0 (en) * 2009-03-27 2009-05-13 Ucl Business Plc Carrier
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US20110070293A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Preparation of Liposomes Comprising Docetaxel
PL226015B1 (pl) * 2011-03-03 2017-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
AU2013360302C1 (en) 2012-12-12 2019-01-24 Temple University - Of The Commonwealth System Of Higher Education Compositions and methods for treatment of cancer
WO2014165829A2 (en) * 2013-04-05 2014-10-09 Igdrasol Nanoparticle formulations
MX2016003265A (es) * 2013-09-13 2016-06-07 Arbor Therapeutics Llc Composiciones nanoparticuladas para administracion dirigida de farmacos lipofilicos y farmacos lipofilicos labiles en medio acido para quimioterapias de cancer y su preparacion.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US4812314A (en) * 1986-02-24 1989-03-14 Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization Lipid replacement therapy
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
ATE194767T1 (de) * 1992-03-23 2000-08-15 Univ Georgetown In liposomen verkapseltes taxol und verwendungsverfahren
WO1994026254A1 (en) * 1993-05-17 1994-11-24 The Liposome Company, Inc. Incorporation of taxol into liposomes and gels
JPH06329533A (ja) * 1993-05-20 1994-11-29 Kyowa Hakko Kogyo Co Ltd リポソーム製剤の製造法
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
DE4430593C2 (de) * 1994-08-20 1999-01-14 Max Delbrueck Centrum Verfahren zur Herstellung von Liposomal verkapseltem Taxol
EP0792143B1 (en) * 1994-11-18 2002-09-04 Aphios Corporation Methods for making liposomes containing hydrophobic drugs
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
WO1997010234A1 (en) * 1995-09-12 1997-03-20 The Liposome Company, Inc. Hydrolysis-promoting taxane hydrophobic derivatives
CA2189916C (en) * 1996-11-08 2001-01-16 Parkash S. Gill A new regime for paclitaxel in kaposi's sarcoma patients

Also Published As

Publication number Publication date
KR20010023522A (ko) 2001-03-26
EA200000282A1 (ru) 2000-10-30
NO20001012D0 (no) 2000-02-29
EP1009384A4 (en) 2004-11-17
US6146659A (en) 2000-11-14
JP2004059590A (ja) 2004-02-26
WO2000001366A1 (en) 2000-01-13
JP2001524990A (ja) 2001-12-04
CA2301057A1 (en) 2000-01-13
AU730599B2 (en) 2001-03-08
AU5088099A (en) 2000-01-24
NO20001012L (no) 2000-03-15
CN1275076A (zh) 2000-11-29
SK4642000A3 (en) 2000-11-07
IL134747A0 (en) 2001-04-30
CA2301057C (en) 2009-03-10
EP1009384A1 (en) 2000-06-21
NZ524490A (en) 2005-04-29
HUP0004583A2 (hu) 2001-08-28
EA003678B1 (ru) 2003-08-28
PL338951A1 (en) 2000-12-04
TR200000576T1 (tr) 2000-11-21
BR9906581A (pt) 2000-09-26

Similar Documents

Publication Publication Date Title
HUP0004583A3 (en) A method for producing medicin containing liposomal encapsulated taxane
HUP0004732A3 (en) Encapsulation method
SG79251A1 (en) Method of assembling a rotary machine
SG65045A1 (en) A method for continuously producing a cyclic formal
AU5932600A (en) Method for making a cosmetic package containing a decorative gel
IL133146A0 (en) A method for producing an isooxazolidinedione compound
EP1142785A4 (en) METHOD FOR PRODUCING LIQUID BAGS
HUP0100943A3 (en) Method for producing polyamides
GB2342203B (en) Drug packaging method
PL348334A1 (en) Method for making a package comprising a peelable zone
GB9809117D0 (en) Method of making a wheel
EP1156915A4 (en) PROCESS FOR PRODUCING FILLED RIGID PLASTIC CONTAINERS
HUP0003768A3 (en) Method for producing thiochloroformates
GB2341490B (en) Method of filling a recess
AU2000239101A1 (en) A method of administering liposomal encapsulated taxane
HUP0100505A3 (en) Method for producing chlorobenzoxazolene
GB2292709B (en) Encapsulation method
GB0115218D0 (en) Method for producing 3-isochromanone
GB9718995D0 (en) Method of producing a package
AU2000275635A1 (en) Method for producing a "kazmin" filled paste
PL329779A1 (en) Method of obtaining a 3-hydroxymethylcepheme compound
SG46940A1 (en) Method for manufacturing prepackaged molding compound for component encapsulation
TW424741U (en) Capsule filling machine
GB9816885D0 (en) A method of producing a dispensing bag
AU738018C (en) A method for producing packages